Peli BioThermal announced expanded dry ice shipper options to support exponential growth in cell and gene therapy shipments worldwide, as well as continued need to transport pandemic payloads. Available parcel sizes range from 1.1 litres to 179 litres and cover temperature ranges of -65 °C to -20°C.
“Cell and gene therapies are highly individualised and patient-centric, which creates a drastically different supply chain than we see for mass-produced pharmaceutical products,” said Greg Wheatley, vice president of worldwide new product development and engineering at Peli BioThermal.
“This supply chain introduces individuals who are not always familiar with cold chain packaging. Our job is to make easy-to-use temperature controlled solutions for these applications.”
Peli BioThermal’s expanded range of dry ice parcels can replace liquid nitrogen systems on short journeys that include a courier. The easy-to-pack parcels are available in single-use Sherpa Systems and DeepFreeze shippers, as well as the reusable Crēdo Cube shippers. The Sherpa Systems shippers range in size from 5 litres to 179 litres, DeepFreeze products are available in 1.1 litre to 8 litre sizes, and Crēdo Cube shippers include 5 litre and 17 litre sizes.
Sherpa Systems use Expanded Polystyrene (EPS) insulation and are moulded with density to achieve required performance standards. DeepFreeze and Crēdo Cube shippers, by contrast, feature high-performance VIP (vacuum insulated panels) that protect the payload and require less dry ice, lowering transportation costs. Dry ice products provide frozen payload protection with durations from 96 hours to 225 hours.
All three systems are cost-effective and easy to pack-out compared to other dry ice frozen shipping products. Additionally, Peli BioThermal shippers undergo constant stress tests in ambient temperatures of 30°C to ensure the payload remains within temperature range for expected durations.
